0 NASDAQ Companies - January 29, 2019Live Ventures to Announce Q1 2019 Earnings and Conduct Conference Call on February 13, 2019LAS VEGAS, Jan. 29, 2019 (GLOBE NEWSWIRE) — Live Ventures Incorporated (NASDAQ: LIVE), a diversified holding company, will host a […]Read More
0 NASDAQ Companies - January 29, 2019scPharmaceuticals Inc. Announces Development Agreement with West Pharmaceutical Services for Next-Generation FUROSCIX® On-Body InfusorAdvancing FUROSCIX® with the SmartDose® Drug Delivery System Forecast 2018 year-end cash of $82 – $87 million and 2019 expenditures […]Read More
0 NASDAQ Companies - January 29, 2019Allakos Announces Positive Phase 2 Results in Patients with Cholinergic Urticaria and Symptomatic Dermographism— 82% (9 of 11) response rate in patients with cholinergic urticaria —— 70% (7 of 10) response rate in […]Read More
0 NASDAQ Companies - January 29, 2019Altimmune Announces Presentation of HepTcell Phase 1 Results at The International Liver Congress™ in Vienna, AustriaGAITHERSBURG, Md., Jan. 29, 2019 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage immunotherapeutics company, today announced results of […]Read More
0 NASDAQ Companies - January 29, 2019Two River Bancorp Reports Record 2018 Fourth Quarter and Annual Financial ResultsTINTON FALLS, N.J., Jan. 29, 2019 (GLOBE NEWSWIRE) — Two River Bancorp (Nasdaq: TRCB) (the “Company”), the parent company of […]Read More
0 NASDAQ Companies - January 29, 2019COURT ORDER DETAILS DIGITAL ALLY’S LITIGATION AGAINST TASERThe Pre-Trial Order Sets Forth the Parties’ Theories and Damages Requests to be Presented to a Jury Lenexa, KS, Jan. […]Read More
0 NASDAQ Companies - January 29, 2019Spero Therapeutics Announces Initiation of SPR720 Phase 1 Clinical TrialCAMBRIDGE, Mass., Jan. 29, 2019 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing […]Read More
0 NASDAQ Companies - January 29, 2019Momenta Pharmaceuticals Announces First Subject Dosed in Phase 1/2 Clinical Trial of M254, Hypersialylated Immunoglobulin GCAMBRIDGE, Mass., Jan. 29, 2019 (GLOBE NEWSWIRE) — Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology company focused on discovering and developing […]Read More
0 NASDAQ Companies - January 29, 2019Enphase Energy Announces Full Repayment of Term Loan DebtFREMONT, Calif., Jan. 29, 2019 (GLOBE NEWSWIRE) — Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the […]Read More
0 NASDAQ Companies - January 29, 2019ShotSpotter Sets Fourth Quarter and Full Year 2018 Conference Call for Tuesday, February 19, 2019 at 4:30 p.m. ETNEWARK, Calif., Jan. 29, 2019 (GLOBE NEWSWIRE) — ShotSpotter, Inc. (NASDAQ: SSTI), the leader in gunshot detection solutions that help […]Read More